NCT03984877 (AMY-TAVI) is a clinical trial of Diagnosis of amyloidosis in Valve Stenoses, Aortic, sponsored by Javier López Pais.

Who is sponsoring NCT03984877?

NCT03984877 is sponsored by Javier López Pais.

What drugs are being tested in NCT03984877?

Interventions in NCT03984877: Diagnosis of amyloidosis.

What condition does NCT03984877 study?

NCT03984877 studies Valve Stenoses, Aortic, Amyloidosis Cardiac.

Is NCT03984877 still recruiting?

NCT03984877 is currently status unknown. Last updated 14 June 2019.

Last reviewed 2019-06-14 · How we verify

NCT03984877: AMY-TAVI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Amyloidosis on TAVI Patients

Status unknown Last updated 14 June 2019

What this trial tests

trial testing Diagnosis of amyloidosis in Valve Stenoses, Aortic in 320 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Javier López Pais
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	320
Start date	1 January 2019
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across Spain

Drugs / interventions tested

Diagnosis of amyloidosis

Conditions studied

Valve Stenoses, Aortic — all drugs for Valve Stenoses, Aortic →
Amyloidosis Cardiac — all drugs for Amyloidosis Cardiac →

Sponsor

Javier López Pais

Who can join

Adults 60 to 110, any sex, with Valve Stenoses, Aortic or Amyloidosis Cardiac. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To analyze the prevalence and impact on the prognosis of amyloidosis due to transthyretin in patients with severe aortic stenosis who undergo percutaneous aortic valve implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03984877 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Javier López Pais
Last refreshed: 14 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03984877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing